Tumour necrosis factor as predictor for pulmonary dysfunction after cardiac surgery
Authors:
- Helen E GillilandHGHelen E Gilliland
- Marilyn A ArmstrongMAMarilyn A Armstrong
- Terence J McMurrayTMTerence J McMurray
- 1 October 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 352 (9136) , 1281-1282
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Genetic influence on cytokine production and fatal meningococcal diseaseThe Lancet, 1997
- Genetic control of multiple sclerosis: Increased production of lymphotoxin and tumor necrosis factor‐α by HLA‐DR2+ T cellsAnnals of Neurology, 1995
- Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groupsThe Lancet, 1993
- High Bronchoalveolar Levels of Tumor Necrosis Factor and Its Inhibitors, Interleukin-1, Interferon, and Elastase, in Patients with Adult Respiratory Distress Syndrome after Trauma, Shock, or SepsisAmerican Review of Respiratory Disease, 1992